Live Breaking News & Updates on Nasdaq Meip|Page 3

Stay updated with breaking news from Nasdaq meip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recent Research Analysts' Ratings Updates for MEI Pharma (MEIP)

MEI Pharma (NASDAQ: MEIP) recently received a number of ratings updates from brokerages and research firms: 11/25/2023 – MEI Pharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 11/17/2023 – MEI Pharma was upgraded by analysts at TheStreet from a “d-” rating to a “c-” rating. 11/17/2023 – […] ....

Securities Exchange Commission , Renaissance Technologies , Pharma Inc , Blackrock Inc , Millennium Management , Pharma Inc Daily , Vanguard Group Inc , Get Free Report , Exchange Commission , Street Corp , Inc Daily , Mei Pharma Inc , Nasdaq Meip ,

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report published on Saturday. The firm issued a hold rating on the stock. A number of other analysts have also weighed in on the company. TheStreet raised MEI Pharma from a d- rating to a c- rating in a research report […] ....

Stifel Nicolaus , Pharma Inc , Simplex Trading , Capital Management , Mirabella Financial Services , Metlife Investment Management , Free Report , Stock Down , Get Free Report , Life Investment Management , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Saturday. The firm issued a hold rating on the stock. Several other equities research analysts also recently commented on the stock. TheStreet upgraded shares of MEI Pharma from a d- rating to a c- rating in a research […] ....

Stifel Nicolaus , Simplex Trading , Securities Exchange Commission , Pharma Inc , Capital Management , Mirabella Financial Services , Metlife Investment Management , Free Report , Stock Down , Get Free Report , Exchange Commission , Life Investment Management , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,

Brokerages Set MEI Pharma, Inc. (NASDAQ:MEIP) Target Price at $29.67

MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) has been given a consensus rating of “Hold” by the six ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The […] ....

Stifel Nicolaus , Simplex Trading , Capital Management , Goldman Sachs Group Inc , Mei Pharma Inc , Charles Schwab Investment Management Inc , Pharma Inc , Get Free Report , Sachs Group , Schwab Investment Management , Two Sigma Investments , Sigma Investments , Get Free , Mei Pharma , Nasdaq Meip ,

MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the stock. Separately, Stifel Nicolaus dropped their price objective on shares of MEI Pharma from $10.00 to $9.00 and set a hold rating on the stock […] ....

Stifel Nicolaus , Simplex Trading , Capital Management , Pharma Inc , Jpmorgan Chase Co , Free Report , Trading Down , Get Free Report , Funds Management , Sigma Investments , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,